Tech

The Download: weight-loss drugs slowing aging and carbon dioxide batteries

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 07/10/2026, 12:20:24 UTC.

Briefings

The Download newsletter reports that GLP-1 weight-loss drugs may slow biological aging by acting on DNA or protein levels, a claim supported by molecular 'aging clocks' from Eli Lilly and Novo Nordisk. Simultaneously, Energy Dome is highlighted as a climate tech company using compressed carbon dioxide to store renewable energy, offering a scalable solution for grids. The newsletter also covers AI developments, including OpenAI's new math findings, Mistral's large model, and Google's halted data center project in Finland. Coverage is limited to the October 7, 2026 edition, with some items like the AI chip glass technology noted as future possibilities.

Key points

• GLP-1 drugs from Eli Lilly and Novo Nordisk are claimed to slow biological aging by acting on DNA or key proteins, supported by molecular 'aging clocks' showing patients age less quickly.
• Energy Dome utilizes compressed carbon dioxide to store renewable energy, offering a scalable solution for grids without requiring specific geology, as featured in the October 7, 2026 edition.

Context and limitations

This briefing covers the October 7, 2026 edition of The Download. Some items, such as the AI chip glass technology, are described as future possibilities rather than current developments. Specific dates for model releases and project orders are noted where available, but uncertainty remains regarding the full scope of the '10 Climate Tech Companies to Watch' list.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 07/10/2026, 13:51:08 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeif2eoae7wtw5khztylplghmiadbnkotekiutkjwittxm7qfo2jioi